Corrigendum to

Cytoprotective and cytotoxic effects of rice bran extracts in rat H9c2(2-1) cardiomyocytes (Oxidative Medicine and Cellular Longevity (2016) 2016 (6943053) DOI: 10.1155/2016/6943053)

Xian Wen Tan, Mrinal Bhave, Alan Yean Yip Fong, Eiji Matsuura, Kazuko Kobayashi, Lian Hua Shen, Siaw San Hwang

Research output: Contribution to journalComment/debate

Abstract

In the article titled "Cytoprotective and Cytotoxic Effects of Rice Bran Extracts in Rat H9c2(2-1) Cardiomyocytes" [1], errors in statistical analyses for inhibitory concentration (IC50) have resulted in incorrect tabulations of data for both Tables 2 and 4. The corrected versions of both tables are as below. Accordingly, in the "Results" (Section 3.1), the text reading "Based on the results (Table 2), the IC50 values of RBE of BJLN were in the range of 61.67 to 64.57 μg/mL over 24, 48, and 72 hours of incubation time." should be corrected to "Based on the results (Table 2), the IC50 values of RBE of BJLN were in the range of 59.57 to 64.27 μg/mL over 24, 48, and 72 hours of incubation time.", and "Based on the results, the IC50 values of MR219 RBE were in the range of 95.44 to 111.50 μg/mL over the three different incubation periods (Table 2)." should be corrected to "Based on the results, the IC50 values of MR219 RBE were in the range of 95.56 to 111.40 μg/mL over the three different incubation periods (Table 2)." In addition, in the "Results" (Section 3.3), the text reading "The positive effects were more distinctive with lower concentrations of RBE (BJLN: 25 μg/mL; MR219: 50 μg/mL) with observable increments in IC50 of H2O2 (BJLN: 645.65 μM; MR219: 320.63 μM) (Table 4) when compared to negative control (316.23 μM). When the two extracts were compared, BJLN (25 μg/mL) extract outran MR219 (50 μg/mL) extract in terms of efficacy with a significant increment in IC50 of H2O2 approximately twofold (645.65 μM) versus 1.4% (in approximation) when compared to negative control (316.23 μM)." should be replaced with "The positive effects were more distinctive with lower concentrations of RBE (BJLN: 25 μg/mL; MR219: 50 μg/mL) with observable increments in IC50 of H2O2 (BJLN: 597.20 μM; MR219: 364.20 μM) (Table 4) when compared to negative control (271.00 μM). When the two extracts were compared, BJLN (25 μg/mL) extract outran MR219 (50 μg/mL) extract in terms of efficacy with a significant increment in IC50 of H2O2 by approximately 2-fold (597.20 μM) versus 1.4-fold (in approximation) when compared to negative control (271.00 μM).", and the text reading "Significant decrements in the IC50 values of H2O2 were found for cell pretreated with 50 μg/mL BJLN (92.90 μM) and 100 μg/mL MR219 (171.79 μM) extracts when compared to negative control (316.23 μM) (Table 4). The higher concentrations of BJLN and MR219 extracts selected were near the range of IC50 of both extracts (IC50 of BJLN: 52.18 μg/mL to 73.09 μg/mL; IC50 of MR219: 95.44 μg/mL to 111.50 μg/mL)." should be replaced with "Significant decrements in the IC50 values of H2O2 were found for cell pretreated with 50 μg/mL BJLN (89.95 μM) and 100 μg/mL MR219 (143.90 μM) extracts when compared to negative control (271.00 μM) (Table 4). The higher concentrations of BJLN and MR219 extracts selected were near the range of IC50 of both extracts (IC50 of BJLN: 59.57 μg/mL to 64.27 μg/mL; IC50 of MR219: 95.56 μg/mL to 111.40 μg/mL)." An incorrect version of Figure 3 with missing graphical elements was published. The corrected version of Figure 3 with the inclusion of graphical elements is as shown below. Accordingly, Figure 5(b) presented in the original manuscript was also the incorrect version. The fourth datum point for MR219 (50 μg/mL) (grey dotted line) was incorrectly plotted. The correct version of the figure is as shown below with the corrected fourth datum point for MR219 (50 μg/mL) (grey dotted line). (Figure Presented).

Original languageEnglish
Article number3136860
JournalOxidative Medicine and Cellular Longevity
Volume2018
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Cardiac Myocytes
Inhibitory Concentration 50
Medicine
Rats
Reading
corrigendum
Oryza
Manuscripts

ASJC Scopus subject areas

  • Biochemistry
  • Ageing
  • Cell Biology

Cite this

@article{939089514d174826ab85b318ff072ec1,
title = "Corrigendum to: Cytoprotective and cytotoxic effects of rice bran extracts in rat H9c2(2-1) cardiomyocytes (Oxidative Medicine and Cellular Longevity (2016) 2016 (6943053) DOI: 10.1155/2016/6943053)",
abstract = "In the article titled {"}Cytoprotective and Cytotoxic Effects of Rice Bran Extracts in Rat H9c2(2-1) Cardiomyocytes{"} [1], errors in statistical analyses for inhibitory concentration (IC50) have resulted in incorrect tabulations of data for both Tables 2 and 4. The corrected versions of both tables are as below. Accordingly, in the {"}Results{"} (Section 3.1), the text reading {"}Based on the results (Table 2), the IC50 values of RBE of BJLN were in the range of 61.67 to 64.57 μg/mL over 24, 48, and 72 hours of incubation time.{"} should be corrected to {"}Based on the results (Table 2), the IC50 values of RBE of BJLN were in the range of 59.57 to 64.27 μg/mL over 24, 48, and 72 hours of incubation time.{"}, and {"}Based on the results, the IC50 values of MR219 RBE were in the range of 95.44 to 111.50 μg/mL over the three different incubation periods (Table 2).{"} should be corrected to {"}Based on the results, the IC50 values of MR219 RBE were in the range of 95.56 to 111.40 μg/mL over the three different incubation periods (Table 2).{"} In addition, in the {"}Results{"} (Section 3.3), the text reading {"}The positive effects were more distinctive with lower concentrations of RBE (BJLN: 25 μg/mL; MR219: 50 μg/mL) with observable increments in IC50 of H2O2 (BJLN: 645.65 μM; MR219: 320.63 μM) (Table 4) when compared to negative control (316.23 μM). When the two extracts were compared, BJLN (25 μg/mL) extract outran MR219 (50 μg/mL) extract in terms of efficacy with a significant increment in IC50 of H2O2 approximately twofold (645.65 μM) versus 1.4{\%} (in approximation) when compared to negative control (316.23 μM).{"} should be replaced with {"}The positive effects were more distinctive with lower concentrations of RBE (BJLN: 25 μg/mL; MR219: 50 μg/mL) with observable increments in IC50 of H2O2 (BJLN: 597.20 μM; MR219: 364.20 μM) (Table 4) when compared to negative control (271.00 μM). When the two extracts were compared, BJLN (25 μg/mL) extract outran MR219 (50 μg/mL) extract in terms of efficacy with a significant increment in IC50 of H2O2 by approximately 2-fold (597.20 μM) versus 1.4-fold (in approximation) when compared to negative control (271.00 μM).{"}, and the text reading {"}Significant decrements in the IC50 values of H2O2 were found for cell pretreated with 50 μg/mL BJLN (92.90 μM) and 100 μg/mL MR219 (171.79 μM) extracts when compared to negative control (316.23 μM) (Table 4). The higher concentrations of BJLN and MR219 extracts selected were near the range of IC50 of both extracts (IC50 of BJLN: 52.18 μg/mL to 73.09 μg/mL; IC50 of MR219: 95.44 μg/mL to 111.50 μg/mL).{"} should be replaced with {"}Significant decrements in the IC50 values of H2O2 were found for cell pretreated with 50 μg/mL BJLN (89.95 μM) and 100 μg/mL MR219 (143.90 μM) extracts when compared to negative control (271.00 μM) (Table 4). The higher concentrations of BJLN and MR219 extracts selected were near the range of IC50 of both extracts (IC50 of BJLN: 59.57 μg/mL to 64.27 μg/mL; IC50 of MR219: 95.56 μg/mL to 111.40 μg/mL).{"} An incorrect version of Figure 3 with missing graphical elements was published. The corrected version of Figure 3 with the inclusion of graphical elements is as shown below. Accordingly, Figure 5(b) presented in the original manuscript was also the incorrect version. The fourth datum point for MR219 (50 μg/mL) (grey dotted line) was incorrectly plotted. The correct version of the figure is as shown below with the corrected fourth datum point for MR219 (50 μg/mL) (grey dotted line). (Figure Presented).",
author = "Tan, {Xian Wen} and Mrinal Bhave and Fong, {Alan Yean Yip} and Eiji Matsuura and Kazuko Kobayashi and Shen, {Lian Hua} and Hwang, {Siaw San}",
year = "2018",
month = "1",
day = "1",
doi = "10.1155/2018/3136860",
language = "English",
volume = "2018",
journal = "Oxidative Medicine and Cellular Longevity",
issn = "1942-0900",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Corrigendum to

T2 - Cytoprotective and cytotoxic effects of rice bran extracts in rat H9c2(2-1) cardiomyocytes (Oxidative Medicine and Cellular Longevity (2016) 2016 (6943053) DOI: 10.1155/2016/6943053)

AU - Tan, Xian Wen

AU - Bhave, Mrinal

AU - Fong, Alan Yean Yip

AU - Matsuura, Eiji

AU - Kobayashi, Kazuko

AU - Shen, Lian Hua

AU - Hwang, Siaw San

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In the article titled "Cytoprotective and Cytotoxic Effects of Rice Bran Extracts in Rat H9c2(2-1) Cardiomyocytes" [1], errors in statistical analyses for inhibitory concentration (IC50) have resulted in incorrect tabulations of data for both Tables 2 and 4. The corrected versions of both tables are as below. Accordingly, in the "Results" (Section 3.1), the text reading "Based on the results (Table 2), the IC50 values of RBE of BJLN were in the range of 61.67 to 64.57 μg/mL over 24, 48, and 72 hours of incubation time." should be corrected to "Based on the results (Table 2), the IC50 values of RBE of BJLN were in the range of 59.57 to 64.27 μg/mL over 24, 48, and 72 hours of incubation time.", and "Based on the results, the IC50 values of MR219 RBE were in the range of 95.44 to 111.50 μg/mL over the three different incubation periods (Table 2)." should be corrected to "Based on the results, the IC50 values of MR219 RBE were in the range of 95.56 to 111.40 μg/mL over the three different incubation periods (Table 2)." In addition, in the "Results" (Section 3.3), the text reading "The positive effects were more distinctive with lower concentrations of RBE (BJLN: 25 μg/mL; MR219: 50 μg/mL) with observable increments in IC50 of H2O2 (BJLN: 645.65 μM; MR219: 320.63 μM) (Table 4) when compared to negative control (316.23 μM). When the two extracts were compared, BJLN (25 μg/mL) extract outran MR219 (50 μg/mL) extract in terms of efficacy with a significant increment in IC50 of H2O2 approximately twofold (645.65 μM) versus 1.4% (in approximation) when compared to negative control (316.23 μM)." should be replaced with "The positive effects were more distinctive with lower concentrations of RBE (BJLN: 25 μg/mL; MR219: 50 μg/mL) with observable increments in IC50 of H2O2 (BJLN: 597.20 μM; MR219: 364.20 μM) (Table 4) when compared to negative control (271.00 μM). When the two extracts were compared, BJLN (25 μg/mL) extract outran MR219 (50 μg/mL) extract in terms of efficacy with a significant increment in IC50 of H2O2 by approximately 2-fold (597.20 μM) versus 1.4-fold (in approximation) when compared to negative control (271.00 μM).", and the text reading "Significant decrements in the IC50 values of H2O2 were found for cell pretreated with 50 μg/mL BJLN (92.90 μM) and 100 μg/mL MR219 (171.79 μM) extracts when compared to negative control (316.23 μM) (Table 4). The higher concentrations of BJLN and MR219 extracts selected were near the range of IC50 of both extracts (IC50 of BJLN: 52.18 μg/mL to 73.09 μg/mL; IC50 of MR219: 95.44 μg/mL to 111.50 μg/mL)." should be replaced with "Significant decrements in the IC50 values of H2O2 were found for cell pretreated with 50 μg/mL BJLN (89.95 μM) and 100 μg/mL MR219 (143.90 μM) extracts when compared to negative control (271.00 μM) (Table 4). The higher concentrations of BJLN and MR219 extracts selected were near the range of IC50 of both extracts (IC50 of BJLN: 59.57 μg/mL to 64.27 μg/mL; IC50 of MR219: 95.56 μg/mL to 111.40 μg/mL)." An incorrect version of Figure 3 with missing graphical elements was published. The corrected version of Figure 3 with the inclusion of graphical elements is as shown below. Accordingly, Figure 5(b) presented in the original manuscript was also the incorrect version. The fourth datum point for MR219 (50 μg/mL) (grey dotted line) was incorrectly plotted. The correct version of the figure is as shown below with the corrected fourth datum point for MR219 (50 μg/mL) (grey dotted line). (Figure Presented).

AB - In the article titled "Cytoprotective and Cytotoxic Effects of Rice Bran Extracts in Rat H9c2(2-1) Cardiomyocytes" [1], errors in statistical analyses for inhibitory concentration (IC50) have resulted in incorrect tabulations of data for both Tables 2 and 4. The corrected versions of both tables are as below. Accordingly, in the "Results" (Section 3.1), the text reading "Based on the results (Table 2), the IC50 values of RBE of BJLN were in the range of 61.67 to 64.57 μg/mL over 24, 48, and 72 hours of incubation time." should be corrected to "Based on the results (Table 2), the IC50 values of RBE of BJLN were in the range of 59.57 to 64.27 μg/mL over 24, 48, and 72 hours of incubation time.", and "Based on the results, the IC50 values of MR219 RBE were in the range of 95.44 to 111.50 μg/mL over the three different incubation periods (Table 2)." should be corrected to "Based on the results, the IC50 values of MR219 RBE were in the range of 95.56 to 111.40 μg/mL over the three different incubation periods (Table 2)." In addition, in the "Results" (Section 3.3), the text reading "The positive effects were more distinctive with lower concentrations of RBE (BJLN: 25 μg/mL; MR219: 50 μg/mL) with observable increments in IC50 of H2O2 (BJLN: 645.65 μM; MR219: 320.63 μM) (Table 4) when compared to negative control (316.23 μM). When the two extracts were compared, BJLN (25 μg/mL) extract outran MR219 (50 μg/mL) extract in terms of efficacy with a significant increment in IC50 of H2O2 approximately twofold (645.65 μM) versus 1.4% (in approximation) when compared to negative control (316.23 μM)." should be replaced with "The positive effects were more distinctive with lower concentrations of RBE (BJLN: 25 μg/mL; MR219: 50 μg/mL) with observable increments in IC50 of H2O2 (BJLN: 597.20 μM; MR219: 364.20 μM) (Table 4) when compared to negative control (271.00 μM). When the two extracts were compared, BJLN (25 μg/mL) extract outran MR219 (50 μg/mL) extract in terms of efficacy with a significant increment in IC50 of H2O2 by approximately 2-fold (597.20 μM) versus 1.4-fold (in approximation) when compared to negative control (271.00 μM).", and the text reading "Significant decrements in the IC50 values of H2O2 were found for cell pretreated with 50 μg/mL BJLN (92.90 μM) and 100 μg/mL MR219 (171.79 μM) extracts when compared to negative control (316.23 μM) (Table 4). The higher concentrations of BJLN and MR219 extracts selected were near the range of IC50 of both extracts (IC50 of BJLN: 52.18 μg/mL to 73.09 μg/mL; IC50 of MR219: 95.44 μg/mL to 111.50 μg/mL)." should be replaced with "Significant decrements in the IC50 values of H2O2 were found for cell pretreated with 50 μg/mL BJLN (89.95 μM) and 100 μg/mL MR219 (143.90 μM) extracts when compared to negative control (271.00 μM) (Table 4). The higher concentrations of BJLN and MR219 extracts selected were near the range of IC50 of both extracts (IC50 of BJLN: 59.57 μg/mL to 64.27 μg/mL; IC50 of MR219: 95.56 μg/mL to 111.40 μg/mL)." An incorrect version of Figure 3 with missing graphical elements was published. The corrected version of Figure 3 with the inclusion of graphical elements is as shown below. Accordingly, Figure 5(b) presented in the original manuscript was also the incorrect version. The fourth datum point for MR219 (50 μg/mL) (grey dotted line) was incorrectly plotted. The correct version of the figure is as shown below with the corrected fourth datum point for MR219 (50 μg/mL) (grey dotted line). (Figure Presented).

UR - http://www.scopus.com/inward/record.url?scp=85048855589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048855589&partnerID=8YFLogxK

U2 - 10.1155/2018/3136860

DO - 10.1155/2018/3136860

M3 - Comment/debate

VL - 2018

JO - Oxidative Medicine and Cellular Longevity

JF - Oxidative Medicine and Cellular Longevity

SN - 1942-0900

M1 - 3136860

ER -